UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Present status and perspective of perioperative chemotherapy for patients with resectable pancreatic cancer in Japan

Global health & medicine, 2022-02, Vol.4 (1), p.14-20, Article 2021.01015

Yamada, Yasuhide

2022

Volltextzugriff (PDF)

Present status and perspective of chemotherapy for patients with unresectable advanced or metastatic gastric cancer in Japan

Global health & medicine, 2020-06, Vol.2 (3), p.156-163

Yamada, Yasuhide

2020

Volltextzugriff (PDF)

Phase I Dose-Escalation and -Expansion Study of the BRAF Inhibitor Encorafenib (LGX818) in Metastatic BRAF -Mutant Melanoma

Clinical cancer research, 2017-09, Vol.23 (18), p.5339-5348

2017

Volltextzugriff (PDF)

Circulating exosomal microRNAs as biomarkers of colon cancer

PloS one, 2014-04, Vol.9 (4), p.e92921-e92921

2014

Volltextzugriff (PDF)

Adipocytokines as new promising markers of colorectal tumors: Adiponectin for colorectal adenoma, and resistin and visfatin for colorectal cancer

Cancer science, 2010-05, Vol.101 (5), p.1286-1291

2010

Volltextzugriff (PDF)

Bevacizumab in Combination With Chemotherapy As First-Line Therapy in Advanced Gastric Cancer: A Randomized, Double-Blind, Placebo-Controlled Phase III Study

Journal of clinical oncology, 2011-10, Vol.29 (30), p.3968-3976

2011

Volltextzugriff (PDF)

Consensus molecular subtypes classification of colorectal cancer as a predictive factor for chemotherapeutic efficacy against metastatic colorectal cancer

Oncotarget, 2018-04, Vol.9 (27), p.18698-18711

2018

Volltextzugriff (PDF)

Optimal chemotherapy for advanced gastric cancer: is there a global consensus?

Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2014-04, Vol.17 (2), p.213-225

2014

Volltextzugriff (PDF)

Adipocytokine levels in gastric cancer patients: resistin and visfatin as biomarkers of gastric cancer

Journal of gastroenterology, 2009-07, Vol.44 (7), p.685-690

2009

Volltextzugriff (PDF)

Phase I study of alpelisib (BYL719), an α‐specific PI3K inhibitor, in Japanese patients with advanced solid tumors

Cancer science, 2019-03, Vol.110 (3), p.1021-1031

2019

Volltextzugriff (PDF)

Phase I study of single‐agent ribociclib in Japanese patients with advanced solid tumors

Cancer science, 2018-01, Vol.109 (1), p.193-198

2018

Volltextzugriff (PDF)

Genome-wide Discovery and Identification of a Novel miRNA Signature for Recurrence Prediction in Stage II and III Colorectal Cancer

Clinical cancer research, 2018-08, Vol.24 (16), p.3867-3877

2018

Volltextzugriff (PDF)

Irinotecan monotherapy as third-line treatment for advanced gastric cancer refractory to fluoropyrimidines, platinum, and taxanes

Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2017-07, Vol.20 (4), p.655-662

2017

Volltextzugriff (PDF)

Randomized phase III trial of regorafenib in metastatic colorectal cancer: analysis of the CORRECT Japanese and non-Japanese subpopulations

Investigational new drugs, 2015-06, Vol.33 (3), p.740-750

2015

Volltextzugriff (PDF)

Serum levels of soluble programmed cell death ligand 1 as a prognostic factor on the first-line treatment of metastatic or recurrent gastric cancer

Journal of cancer research and clinical oncology, 2016-08, Vol.142 (8), p.1727-1738

2016

Volltextzugriff (PDF)

Transcriptomic expression profiling identifies ITGBL1, an epithelial to mesenchymal transition (EMT)-associated gene, is a promising recurrence prediction biomarker in colorectal cancer

Molecular cancer, 2019-02, Vol.18 (1), p.19-19, Article 19

2019

Volltextzugriff (PDF)

Multicenter Phase II Study of Everolimus in Patients With Previously Treated Metastatic Gastric Cancer

Journal of clinical oncology, 2010-04, Vol.28 (11), p.1904-1910

2010

Volltextzugriff (PDF)

Impact of CYP genotype and inflammatory markers on the plasma concentrations of tramadol and its demethylated metabolites and drug tolerability in cancer patients

European journal of clinical pharmacology, 2018-11, Vol.74 (11), p.1461-1469

2018

Volltextzugriff (PDF)

Real impact of oxaliplatin in adjuvant chemotherapy for patients with stage III colon cancer based on the Multi-Institutional Registry of Large Bowel Cancer in Japan

Global health & medicine, 2022-10, Vol.4 (5), p.259-267, Article 2022.01048

2022

Volltextzugriff (PDF)

Genome-wide Discovery of a Novel Gene-expression Signature for the Identification of Lymph Node Metastasis in Esophageal Squamous Cell Carcinoma

Annals of surgery, 2019-05, Vol.269 (5), p.879-886

2019

Volltextzugriff (PDF)

DNA methylation status as a biomarker of anti‐epidermal growth factor receptor treatment for metastatic colorectal cancer

Cancer science, 2015-12, Vol.106 (12), p.1722-1729

2015

Volltextzugriff (PDF)

A comprehensive methylation signature identifies lymph node metastasis in esophageal squamous cell carcinoma

International journal of cancer, 2019-03, Vol.144 (5), p.1160-1169

2019

Volltextzugriff (PDF)

A Reversed-Phase Mode LC-MS/MS Method Using a Polysaccharide Chiral Selector for Simultaneous Quantitation of Each Enantiomer of Tramadol and its Metabolites in Human Plasma and Evaluation of CYP-Mediated Stereoselective Demethylation

Therapeutic drug monitoring, 2020-06, Vol.42 (3), p.503-511

2020

Volltextzugriff (PDF)

microRNA-193a-3p is specifically down-regulated and acts as a tumor suppressor in BRAF-mutated colorectal cancer

BMC cancer, 2017-11, Vol.17 (1), p.723-723, Article 723

2017

Volltextzugriff (PDF)

1 – 25 von 641

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(533)
Mit Volltextzugriff
(576)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(347)
Life Sciences & Biomedicine
(322)
Humans
(305)
Male
(250)
Female
(234)
Oncology
(206)
Middle Aged
(196)
Aged
(188)
Adult
(178)
Biological And Medical Sciences
(103)
Medical Sciences
(99)
Medicine
(85)
Tumors
(82)
Treatment Outcome
(78)
Medicine & Public Health
(77)
Cancer Research
(67)
Chemotherapy
(67)
Colorectal Cancer
(60)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(59)
Gastric Cancer
(55)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Present status and perspective of perioperative chemotherapy for patients with resectable pancreatic cancer in Japan

Present status and perspective of chemotherapy for patients with unresectable advanced or metastatic gastric cancer in Japan

Phase I Dose-Escalation and -Expansion Study of the BRAF Inhibitor Encorafenib (LGX818) in Metastatic BRAF -Mutant Melanoma

Circulating exosomal microRNAs as biomarkers of colon cancer

Adipocytokines as new promising markers of colorectal tumors: Adiponectin for colorectal adenoma, and resistin and visfatin for colorectal cancer

Bevacizumab in Combination With Chemotherapy As First-Line Therapy in Advanced Gastric Cancer: A Randomized, Double-Blind, Placebo-Controlled Phase III Study

Consensus molecular subtypes classification of colorectal cancer as a predictive factor for chemotherapeutic efficacy against metastatic colorectal cancer

Optimal chemotherapy for advanced gastric cancer: is there a global consensus?

Adipocytokine levels in gastric cancer patients: resistin and visfatin as biomarkers of gastric cancer

Phase I study of alpelisib (BYL719), an α‐specific PI3K inhibitor, in Japanese patients with advanced solid tumors

Leucovorin, fluorouracil, and oxaliplatin plus bevacizumab versus S-1 and oxaliplatin plus bevacizumab in patients with metastatic colorectal cancer (SOFT): an open-label, non-inferiority, randomised phase 3 trial

Phase I study of single‐agent ribociclib in Japanese patients with advanced solid tumors

Genome-wide Discovery and Identification of a Novel miRNA Signature for Recurrence Prediction in Stage II and III Colorectal Cancer

Irinotecan monotherapy as third-line treatment for advanced gastric cancer refractory to fluoropyrimidines, platinum, and taxanes

Randomized phase III trial of regorafenib in metastatic colorectal cancer: analysis of the CORRECT Japanese and non-Japanese subpopulations

Serum levels of soluble programmed cell death ligand 1 as a prognostic factor on the first-line treatment of metastatic or recurrent gastric cancer

Transcriptomic expression profiling identifies ITGBL1, an epithelial to mesenchymal transition (EMT)-associated gene, is a promising recurrence prediction biomarker in colorectal cancer

Multicenter Phase II Study of Everolimus in Patients With Previously Treated Metastatic Gastric Cancer

Impact of CYP genotype and inflammatory markers on the plasma concentrations of tramadol and its demethylated metabolites and drug tolerability in cancer patients

Real impact of oxaliplatin in adjuvant chemotherapy for patients with stage III colon cancer based on the Multi-Institutional Registry of Large Bowel Cancer in Japan

Genome-wide Discovery of a Novel Gene-expression Signature for the Identification of Lymph Node Metastasis in Esophageal Squamous Cell Carcinoma

DNA methylation status as a biomarker of anti‐epidermal growth factor receptor treatment for metastatic colorectal cancer

A comprehensive methylation signature identifies lymph node metastasis in esophageal squamous cell carcinoma

A Reversed-Phase Mode LC-MS/MS Method Using a Polysaccharide Chiral Selector for Simultaneous Quantitation of Each Enantiomer of Tramadol and its Metabolites in Human Plasma and Evaluation of CYP-Mediated Stereoselective Demethylation

microRNA-193a-3p is specifically down-regulated and acts as a tumor suppressor in BRAF-mutated colorectal cancer

Suchergebnisse filtern